Arturo Molina M.D., Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 15,000 shares at $104.79 ($1.6M) on 2026-03-26, disclosed to the SEC on 2026-03-27.
Open-market sale of $1.6M PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTGX | SELL | 2025-11-19 | $460K | — | Filing → |
| PTGX | SELL | 2025-06-11 | $1.1M | — | Filing → |
| PTGX | SELL | 2025-03-14 | $3.4M | — | Filing → |